For Immediate Release

GlycoNet and NOVA School of Science and Technology (NOVA FCT) sign MOU to collaborate and advance the next frontier of bioinnovation

Under a new agreement, GlycoNet and NOVA FCT will leverage their combined expertise in the study of carbohydrates for knowledge exchange, collaborative research and training opportunities.

EDMONTON, ALBERTA (May 28, 2024) – GlycoNet, one of the world’s leaders in glycomics, has signed a memorandum of understanding (MOU) agreement with the NOVA School of Science and Technology (NOVA FCT) to collaborate and advance the fields of glycomics and glycoscience, which involve the study of carbohydrates or sugars in biological systems.  

Both GlycoNet and NOVA FCT bring together world-leading experts in glycomics and glycoscience to provide diverse innovation ecosystems that support translational research with state-of-the-art tools and resources. GlycoNet is a pan-Canadian glycomics research network and includes GlycoNet Integrated Services (GIS), providing access to cutting-edge technologies and infrastructure for researchers and clients worldwide. NOVA FCT is one of the three largest schools in engineering and sciences in Portugal and is home to researchers with expertise in glycoscience and leading GLYCOTwinning, a Horizon Europe-funded capacity-building network that aims to promote scientific excellence, innovation and research infrastructures in glycomics.  

“By studying the critical roles that carbohydrates play in many biological processes, glyco-scientists are developing new tools and strategies to improve human, animal, and environmental health,” said Dr. Elizabeth Nanak, CEO of GlycoNet. “This exciting partnership with NOVA FCT will support glycomics innovation through international collaboration, networking, and training opportunities for students and researchers in both Canada and Portugal.” 

The MOU represents the establishment of closer ties between GlycoNet and NOVA FCT. They will explore opportunities to collaborate, promote networking and cross-training, and share best practices and resources that support their joint commitment to advancing glycomics and glycoscience.  

“We are proud to sign this MOU with GlycoNet and combine our expertise to accelerate glycoscience innovation together,” said Dr. Paula Videira, NOVA FCT, one of the coordinators of GLYCOTwinning. “Glycoscience as a rapidly growing field holds so much technological potential, and collaboration in research is essential to leveraging that to address complex problems more effectively and translate into effective solutions to improve human health.” 

Mobilizing the exchange of knowledge and expertise in the fields of glycomics and glycoscience beyond borders is critical to understanding global challenges in health and sustainability, as well as developing more robust solutions to address those challenges. Together we can build more self-sufficient, sustainable and thriving communities. 

GlycoNet and NOVA FCT look forward to an opportunity for networking and knowledge sharing at the upcoming 2024 Canadian Glycomics Symposium, taking place May 27-29 in Edmonton, Alberta. Dr. Videira will be giving a keynote presentation on “Glycoimmunology at the Crossroads: Impact of Sialylated Glycan Expression and Recognition in Cancer, Immunology, and Rare Diseases. 

 

About GlycoNet 
GlycoNet is a pan-Canadian research network consisting of over 190 researchers in 36 institutions across the country participating in over 140 funded projects. GlycoNet investigators use the study of carbohydrates (sugars) in living cells to find solutions to unmet health needs through the development of tools, drugs, vaccines and diagnostics. Taking a One-Health approach that considers the connections among human, animal and environmental health, GlycoNet is advancing research, innovation and training in glycomics to improve quality of life for Canadian. Under the network, GlycoNet Integrated Services (GIS) operates as a national platform of glycomics services. GlycoNet and GIS together provide one-stop access to glycomics tools, specialized expertise, consulting, and collaborative opportunities to academia and industry, both nationally and internationally. GlycoNet is also a leader in training the next generation of glyco-scientists and promoting collaboration and advancement in glycomics research. GlycoNet is supported in part  through the Government of Canada’s Strategic Science Fund. Learn more on our website: glyconet.ca.

About NOVA FCT 
NOVA School of Science and Technology (NOVA FCT) is one of the three largest and most prestigious schools of Engineering and Sciences in Portugal. It is structured in 13 departments and renowned for its excellence in research, for the quality of its courses and for the large employability of its graduates. The Research Unit on Applied Molecular Biosciences (UCIBIO) combines critical expertise in chemistry and biological sciences and is committed to excellence in glycoscience. UCIBIO holds specific expertise in glycoimmunology applied to the identification of glycan-based therapies for oncology and congenital disorders of glycosylation; molecular recognition of glycans using integrative structural biology approaches, especially NMR; and specific expertise in integrative glycomic-scale glycan microarray approaches for glycan-ligand discovery. The impact of NOVA FCT and UCIBIO in glycoscience is well demonstrated by a significant number of research outputs including numerous scientific publications, coordination of international and national projects, granted intellectual property and services. Researchers Dr. Paula Videira, Dr. Angelina de Sá Palma and Dr. Filipa Marcelo are leading the GLYCOTwinning European project that builds upon this demonstrated capacity to promote scientific excellence and innovation in glycoscience. Learn more on our website: GLYCOTwinning.eu.

Media Contact
Elizabeth Nanak
Chief Executive Officer
enanak@ualberta.ca
780-492-7784 

NOVA FCT Contact
Tomé Azevedo
Project Manager GLYCOTwinning
tome.azevedo@fct.unl.p

Discover more from GlycoNet News.

© CANADIAN GLYCOMICS NETWORK (GLYCONET). ALL RIGHTS RESERVED.

en_USEnglish
Scroll to Top